Filing Flows

Filing Flows › AdvanSix (ASIX) › Q2 2026 › vs Q2 2025

AdvanSix (ASIX) Q2 2026 vs Q2 2025 (year over year)

AdvanSix's revenue rose $11.3M (+3%) from $410M in Q2 2025 to $421M in Q2 2026. The biggest changes: Plant Nutrients −$25.3M (-16%); Nylon +$20.7M (+26%); Chemical Intermediates +$19.7M (+18%). Operating margin 1.6% against 7.7% (-6.1 pts).

AdvanSix, Q2 2026: revenue $421M (+3% year over year), operating margin 1.6%, net earnings $3.2M, operating cash flow $10.0M. The chart draws each line against Q2 2025, the increases inside each band.

AdvanSix: what changed, Q2 2026 vs Q2 2025AdvanSix: what changed, Q2 2026 vs Q2 2025Cost of revenue$38.9MCosts & expenses$36.3MNet earnings−$28.1MOperating cash sources−$27.3MPlant Nutrients−$25.3MOperating profit−$25.0MPre-tax earnings−$25.0MNylon$20.7MChemical Intermediates$19.7MWorking capital & other−$16.2M

Margins

Q2 2026Q2 2025Change
Operating margin1.6%7.7%-6.1 pts
Net margin0.8%7.7%-6.9 pts

Every line

LineQ2 2026Q2 2025Change%
Plant Nutrients$131M$157M−$25.3M-16%
Chemical Intermediates$127M$107M$19.7M+18%
Nylon$100M$79.5M$20.7M+26%
Caprolactam$62.6M$66.4M−$3.8M-6%
Revenue$421M$410M$11.3M+3%
Operating profit$6.7M$31.6M−$25.0M-79%
Costs & expenses$415M$378M$36.3M+10%
Pre-tax earnings$6.7M$31.6M−$25.0M-79%
Cost of revenue$390M$351M$38.9M+11%
SG&A$22.1M$25.4M−$3.4M-13%
Other operating costs$2.4M$1.6M$745K+45%
Net earnings$3.2M$31.4M−$28.1M-90%
Income tax$3.4M$279K$3.1M12×
Operating cash sources$25.9M$53.1M−$27.3M-51%
Depreciation & amortization$20.8M$19.5M$1.3M+7%
Share-based compensation$1.8M$2.3M−$476K-21%
Working capital & other$15.8M$32.0M−$16.2M-51%
Operating cash flow$10.0M$21.1M−$11.1M-52%
Capital expenditures$20.7M$28.3M−$7.6M-27%
Negative free cash flow (OCF − capex)$10.7M$7.2M$3.5M+49%

Questions

How much did AdvanSix's revenue grow year over year in Q2 2026?

AdvanSix's revenue rose $11.3M (+3%) from $410M in Q2 2025 to $421M in Q2 2026.

What drove AdvanSix's revenue change in Q2 2026?

Plant Nutrients −$25.3M (-16%); Nylon +$20.7M (+26%); Chemical Intermediates +$19.7M (+18%).

Q2 2026 results → · Compare in the interactive Sankey →